Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1975-7-24
|
| pubmed:abstractText |
Eleven patients with terminal metastatic prostatic carcinoma were selected for a pilot study to evaluate how effective diethylstilbestrol diphosphate (Stilphostrol) and cylcophosphamide (Cytoxan) are in this disease. Six of 7 patients had a good response when treated with diethylstilbestrol diphosphate. The mean duration of response was 6.4 months. All 6 patients given cyclophosphamide had marked relief of pain and increased mobility. Of these, 3 died twelve, sixteen, and nineteen weeks, respectively, following initiation of therapy while still benefiting from pain relief. The mean duration of response was 14.8 weeks.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0090-4295
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
5
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
665-8
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:48303-Adenocarcinoma,
pubmed-meshheading:48303-Cyclophosphamide,
pubmed-meshheading:48303-Diethylstilbestrol,
pubmed-meshheading:48303-Humans,
pubmed-meshheading:48303-Male,
pubmed-meshheading:48303-Palliative Care,
pubmed-meshheading:48303-Pilot Projects,
pubmed-meshheading:48303-Prostatic Neoplasms
|
| pubmed:year |
1975
|
| pubmed:articleTitle |
Management of adenocarcinoma of prostate with diethylstilbestrol diphosphate and cyclophosphamide.
|
| pubmed:publicationType |
Journal Article
|